Recent insider trends for Medical Transcription Billing, Corp. (NASDAQ:MTBC) have caught the attention of investors. Insider activity is often a strong indicator of future performance in a stock, and if the data on MTBC is anything to go by, investors should pay attention.
Institutions own 07.44% of Medical Transcription Billing, Corp. (MTBC)’s shares. The total value of these holdings, in millions, is $3. Among active positions in the latest quarter, 8 holders increased their positions by a total of 114125 shares, 3 holders decreased the positions by a total of 351742 shares, and 1 holders held their positions. This works out to a net decrease in ownership of 237617 shares, and suggests that institutions are feeling bearish about the stock.
Among new and sold out positions, 7 holders initiated new positions by a total of 92403 shares and 1 holders exited their positions by a total of 23694 shares. This nets out to an increase of 68709 shares and is a bullish sign for MTBC.
In the last three months, insiders executed a total of 9 trades. 9 were sells. Insider ownership decreased by a total of 25950 shares, which suggests that MTBC’s key executives are feeling less optimistic about the outlook for the stock. The data from the past twelve months tells a different story: insiders executed 9 buys and 16 sells, and ownership increased by a net of 190466 shares.
Comparing the number of shares sold short over time is a method analysts often use to get a reading on investor sentiment. Medical Transcription Billing, Corp. (NASDAQ:MTBC)’s short interest is 587000 shares, or 17.49% of the float. This represents a decrease of -14% in the number of shares being shorted compared to the previous reading, and implies that investors felt less pessimistic about the stock during the past two weeks.
Given what the insider ownership patterns are saying, it makes sense to consider the technicals to see if these pieces of information reach the same conclusion about the outlook for MTBC. A composite of 13 technical indicators that includes measures such as moving averages and momentum oscillators suggests that MTBC is a Strong buy, which implies that MTBC is expected to outperform the market based on prior trading patterns.
Institutional ownership trends suggest that the stock is cheap and the insider trading data indicates that insiders are bearish. Technical indicators (also) suggest that Medical Transcription Billing, Corp. (NASDAQ:MTBC) is undervalued.